CAT
Caterpillar Inc.
CAT has the edge over SPCB overall, supported by stronger modeled upside and lower modeled downside.
SPCB
SuperCom Ltd.
SPCB offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
SPCB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Weak |
SPCB's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is weak.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over SPCB in the historical PE scenario, which offers more potential upside but is not a forecast.
SPCB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $6.66 | — |
| Cheap | 16x | $2.50 | -62% |
| Fair | 18x | $2.91 | -56% |
| Expensive | 38x | $6.05 | -9.1% |
| Current | 42x | $6.66 | — |
Historical ranges are pointers, not guarantees.
SPCB's PE is 42x, but its earnings don't support one, so it isn't a reliable read right now.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
CAT has the edge over SPCB on the outlook, with more favorable profitability expectations.
SPCB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for SPCB, but weaker profitability. However, they disagree widely on these estimates.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over SPCB in the latest year-over-year earnings comparison.
SPCB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.59 | +272% |
| Q2 2026 | $0.16 | -79% |
SPCB earned $0.16 per share over the past year, down 79% from the year before.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over SPCB on profitability, with a higher operating margin.
SPCB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.1M | +13% |
| Q1 2026 | $7.6M | +8% |
| Q4 2025 | $7.5M | +13% |
| Q3 2025 | $6.2M | -9.9% |
| Q2 2025 | $7.1M | -5.4% |
| Q1 2025 | $7M | +2.9% |
| Q4 2024 | $6.6M | +17% |
| Q3 2024 | $6.9M | +2% |
SPCB's revenue has picked up after two years of holding roughly level: $8M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | -2.5 points |
| Q1 2026 | 17% | -0.6 points |
| Q4 2025 | -12% | +2.6 points |
| Q3 2025 | 12% | +11 points |
| Q2 2025 | 17% | +12 points |
| Q1 2025 | 17% | +6.8 points |
| Q4 2024 | -14% | +30 points |
| Q3 2024 | 1.8% | -11 points |
SPCB's operating margin was 14% last quarter, down 2.5 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over SPCB on cash flow, with more consistent year-over-year improvement.
SPCB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$666K |
| Q3 2025 | $0 | +$666K |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$666K | -$666K |
| Q3 2024 | -$666K | -$666K |
SPCB's free cash flow was $0 over the past year, against −$1M the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over SPCB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
SPCB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +14K shares |
| 1 year | +59% | +2.1M shares |
SPCB has 6M diluted shares, up 59% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $24,500 |
| Q3 2024 | $24,500 |
SPCB hasn't bought back shares in the past year.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over SPCB on leverage, with a lower net debt burden relative to earnings.
SPCB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 5.0x | High |
| Q1 2026 | 3.2x | Elevated |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.0x | Healthy |
| Q2 2025 | 1.1x | Healthy |
| Q1 2025 | 0.9x | Very low |
| Q4 2024 | 5.0x | High |
| Q3 2024 | 5.4x | High |
SPCB's net debt is about 5.0 years of its operating earnings (EBITDA), up from 1.1 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SPCB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 17.9 | Oversold |
SPCB's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over SPCB on valuation relative to its sector.
SPCB PE vs Industrials Sector
| Metric | SPCB | Sector median | Relative |
|---|---|---|---|
| PE | 42x | 24x | 73% above |
| PE % | 93 | 58 | 35 pts above |
SPCB is trading at 42x earnings, a 73% premium to the Industrials sector's median of 24x, though its earnings don't support one.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over SPCB on trend strength, trading above more of its moving averages.
SPCB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.88 | 25% below |
| 20 week MA | $9.99 | 33% below |
| 50 week MA | $9.64 | 31% below |
| 100 week MA | $9.45 | 30% below |
| 200 week MA | $10.7 | 38% below |
SPCB is in a downtrend: it's below all five of its weekly moving averages, and 38% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over SPCB on returns for 2026, with the stronger performance.
SPCB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $129.0 | $212.0 | +64% |
| 2021 | $212.0 | $106.2 | -50% |
| 2022 | $106.2 | $40.0 | -62% |
| 2023 | $40.0 | $7.72 | -81% |
| 2024 | $7.72 | $3.84 | -50% |
| 2025 | $3.84 | $9.35 | +143% |
| 2026 YTD | $9.35 | $6.66 | -29% |
SPCB's yearly returns have swung widely, from +143% in 2025 to −81% in 2023. It's down 29% so far in 2026.